To the Editor: We write in response to the excellent review by Allen and colleagues1 and to highlight the recent introduction of national surveillance for Japanese encephalitis by the Australian Paediatric Surveillance Unit (APSU) (www.apsu.org.au).
- 1. Allen S, Cooper CM, Taranath A, et al. Japanese encephalitis virus: changing the clinical landscape of encephalitis in Australia. Med J Aust 2023; 218: 344‐347. https://www.mja.com.au/journal/2023/218/8/japanese‐encephalitis‐virus‐changing‐clinical‐landscape‐encephalitis‐australia
- 2. World Health Organization. Japanese encephalitis — Australia. Geneva: WHO, 2022. https://www.who.int/emergencies/disease‐outbreak‐news/item/2022‐DON365 (viewed Aug 2023).
- 3. Australian Government, Department of Health and Aged Care. Japanese encephalitis. Canberra: Commonwealth of Australia, 2023. https://www.health.gov.au/diseases/japanese‐encephalitis (viewed Aug 2023).
- 4. Mackenzie JS, Williams DT, van den Hurk AF, et al. Japanese encephalitis virus: the emergence of genotype IV in Australia and its potential endemicity. Viruses 2022; 14: 2480.
- 5. Furlong M, Adamu AM, Hoskins A, et al. Japanese encephalitis enzootic and epidemic risks across Australia. Viruses 2023; 15: 450.
- 6. Yakob L, Hu W, Frentiu FD, et al. Japanese encephalitis emergence in Australia: the potential population at risk. Clin Infect Dis 2023; 76: 335‐337.
- 7. Mackenzie JS, Smith DW, Speers DJ. Japanese encephalitis disease: overview of the virus, its risk to Australia and the need for better surveillance. Intern Med J 2022; 52: 2029‐2033.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.